Author

C. Bernuy

Observed names: C Bernuy, Coralina Bernuy, Coralina Bernuy-Guevara

Institution: Universidad de Valladolid

Observed institutions: Universidad de Valladolid, Hospital Universitario La Paz, Hospital Universitario Miguel Servet, Hospital General Yagüe, Hospital Universitario Fundación Jiménez Díaz, Hospital Universitario de La Princesa, Hospital de Cruces, Hospital Vital Álvarez-Buylla

ORCID: 0000-0002-5055-3493

Observed ORCID: 0000-0002-5055-3493

OpenAlex ID: A5073089018

Long‐term follow‐up of a randomized prospective trial comparing a standard 81 mg dose of intravesical bacille Calmette‐Guérin with a reduced dose of 27 mg in superficial bladder cancer

2002 · J.A. Martínez‐Pin˜eiro, N. Flores, et al. · British Journal of Urology · 222

Near-Infrared Spectroscopy Monitoring in Cardiac and Noncardiac Surgery: Pairwise and Network Meta-Analyses

2019 · Christian Ortega-Loubon, Francisco Herrera-Gómez, et al. · Journal of Clinical Medicine · 58

Long-term follow-up of a randomized prospective trial comparing a standard 81mg dose of intravesical bacille calmette-guérin with a reduced dose of 27mg in superficial bladder cancer.

2003 · J.A Martinez-Pineiro, N Flores, et al. · Urologic Oncology Seminars and Original Investigations · 53

The Inhibition of Complement System in Formal and Emerging Indications: Results from Parallel One-Stage Pairwise and Network Meta-Analyses of Clinical Trials and Real-Life Data Studies

2020 · Coralina Bernuy-Guevara, Hassib Chehade, et al. · Biomedicines · 25

Random trial comparing intravesical chemo-induction with MMC to BCG vs. intravesical BCG, in patients with intermediate-high risk superficial bladder cancer. Efficacy evaluation of CUETO Trial No 93008

2002 · E. Solsona, M. Gonzalez, et al. · European Urology Supplements · 3

Lynch syndrome diagnostics: decision-making process for germ-line testing

2012 · Enrique Lastra, María García-González, et al. · Clinical & Translational Oncology · 2

486 Random trial comparing intravesical chemo-induction with MMC to BCG vs. intravesical BCG, in patients with intermediate-high risk superficial bladder cancer. Final report of efficacy evaluation of cueto trial N°93009

2004 · E. Solsona, I. Gonzalez, et al. · European Urology Supplements · 1

Works count: 7

Citation count: 364

H-index: 4

I10-index: 4